• PMO team

Position for a post Doc available at the Medical University of Vienna - Department of Rheumatology

Updated: Nov 18, 2019

The position is funded by the Austrian Science Fund (FWF), project no. SFB-F70.

  • Application deadline: December 6th, 2019

  • Start date: January 2020

  • Duration: up to 4 years

Project title: The role of HDAC-mediated Epigenetic Modifications in T-cells for the Pathogenesis of Rheumatoid Arthritis (RA)


The field: Immunology, Rheumatology, T-cell biology, Bioinformatics


The project: We are looking for a highly motivated Postdoc who is interested to perform research in the field of autoimmunity and inflammation. The project aims to understand the role of HDACs for the development of arthritis in a T cell-dependent arthritis model, as well as in patients with RA. Chromatin profiling will determine enhancer signatures of T-cells from RA patients and in a T-cell dependent arthritis model. Experiments are designed to understand and explore the potential of HDAC inhibitors to reprogram a pathogenic signature.

The approach entails state-of-the-art technologies, including transcriptomic and epigenomic analysis (histone modifications such as methylation and acetylation), as well as advanced cell biology techniques, including the use of in vivo models. This will enable the integration of murine and human datasets, and provide a rationale for the use of new-generation HDAC inhibitors for the treatment of autoimmune diseases.


The research group: The project is under the supervision of Michael Bonelli at the Department of Rheumatology at the MedUniWien. The group is embedded in the FWF-funded SFB program “HDACs as regulators of T cell-mediated immunity in health and disease“. Participation in this program offers unique opportunities for PhD students to collaborate with international experts in the field and to apply cutting-edge technologies, including transcriptomics, proteomics, and epigenomics, as well as advanced cell biology and immunology.


The candidate: Applicants should hold a PhD in molecular biology, medicine, immunobiology or a related discipline and ideally have documented experience in molecular biology, mammalian cell culture methods and mouse models. Previous experience with immunological assays, primary cell cultures, flow cytometry and bioinformatics analysis are advantageous.


Application: Interested candidates should send their application (letter of motivation, curriculum vitae, high school diploma, a brief synopsis of your PhD thesis, at least 2 letters of recommendation) to:


Michael Bonelli, MD PhD

Email: michael.bonelli@meduniwien.ac.at

Phone:+43-1-40400-43010

8 views

Recent Posts

See All

Two PRP's share about their involvement with RTCure

Tom Esterine and Ruth Williams are two Expert Patients at King’s College London, who work with Heidi Lempp in the Centre for Rheumatic Disease. With a lot of enthusiasm, they share their insight in wo

PRP Newsletter - May 2020

Following this link you can find the EULAR Patient Research Partners newsletter of May 2020. This newsletter contains an invitation to the virtual EULAR 2020 E-Congress, links to interesting articles

  • Follow us on Twitter

Follow us on Twitter:

The RTCure project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement no 777357. This joint undertaking receives support from the European Union's Horizon 2020 Research and Innovation Programme and EFPIA.

The communication reflects the author's view; neither IMI nor the European Union or EFPIA  are responsible for any use that may be made of the information contained herein.